These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1480680)

  • 41. [Follow-up dynamics of schizophrenic diseases in adolescence].
    Schulz E; Martin M; Remschmidt H
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of enduring deficit and negative symptom subtypes in schizophrenia.
    Mueser KT; Douglas MS; Bellack AS; Morrison RL
    Schizophr Bull; 1991; 17(4):565-82. PubMed ID: 1805350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor structure of symptoms in functional psychoses.
    Peralta V; Cuesta MJ; Farre C
    Biol Psychiatry; 1997 Nov; 42(9):806-15. PubMed ID: 9347129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative symptoms and affective disturbance in schizophrenia and related disorders.
    Malla AK
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S55-9. PubMed ID: 8564918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three syndromes in schizophrenia: validity in young patients with recent onset of illness.
    Gureje O; Aderibigbe YA; Obikoya O
    Psychol Med; 1995 Jul; 25(4):715-25. PubMed ID: 7480449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The complex relationships between executive functions and positive symptoms in schizophrenia.
    Guillem F; Rinaldi M; Pampoulova T; Stip E
    Psychol Med; 2008 Jun; 38(6):853-60. PubMed ID: 18261245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.
    Tibbo P; Swainson J; Chue P; LeMelledo JM
    Depress Anxiety; 2003; 17(2):65-72. PubMed ID: 12621594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia.
    Van der Does AJ; Linszen DH; Dingemans PM; Nugter MA; Scholte WF
    J Nerv Ment Dis; 1993 Dec; 181(12):744-9. PubMed ID: 8254326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence and correlates of trauma-related symptoms in schizophrenia spectrum disorder.
    Lysaker PH; Larocco VA
    Compr Psychiatry; 2008; 49(4):330-4. PubMed ID: 18555051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ["Primary and secondary negative symptoms: a reliable differentiation?" Comment on the contribution by W. Barnett et al].
    Amminger GP; Kirkpatrick B
    Nervenarzt; 1997 May; 68(5):438-40. PubMed ID: 9280857
    [No Abstract]   [Full Text] [Related]  

  • 53. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance.
    Pogue-Geile MF; Harrow M
    Schizophr Bull; 1985; 11(3):427-39. PubMed ID: 4035306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychometric properties of the Manchester Scale.
    Jackson HJ; Burgess PM; Minas IH; Joshua SD
    Acta Psychiatr Scand; 1990 Feb; 81(2):108-13. PubMed ID: 2327271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
    Liu SK; Hwu HG; Chen WJ
    Schizophr Res; 1997 Jun; 25(3):211-9. PubMed ID: 9264176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioural Observation Schedule (BOS), PIRS 2nd edition. A revised edition of the PIRS (WHO, Geneva, March 1978).
    Atakan Z; Cooper JE
    Br J Psychiatry Suppl; 1989 Nov; (7):78-88. PubMed ID: 2619985
    [No Abstract]   [Full Text] [Related]  

  • 57. The functional significance of symptomatology and cognitive function in schizophrenia.
    Velligan DI; Mahurin RK; Diamond PL; Hazleton BC; Eckert SL; Miller AL
    Schizophr Res; 1997 May; 25(1):21-31. PubMed ID: 9176924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insight in schizophrenia and its relationship to psychopathology.
    Kemp RA; Lambert TJ
    Schizophr Res; 1995 Dec; 18(1):21-8. PubMed ID: 8929757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component.
    Daneluzzo E; Arduini L; Rinaldi O; Di Domenico M; Petruzzi C; Kalyvoka A; Rossi A
    Schizophr Res; 2002 Jul; 56(1-2):129-36. PubMed ID: 12084427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic criteria in schizophrenia: accentuate the positive.
    David AS; Appleby L
    Schizophr Bull; 1992; 18(4):551-7. PubMed ID: 1439612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.